Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, and the old AstraZeneca study locator contact block was removed.
    Difference
    0.0%
    Check dated 2026-05-15T23:59:17.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s footer has updated the ClinicalTrials.gov interface revision/version from v3.5.2 to v3.5.3. This reflects a platform update rather than a change to the displayed study details.
    Difference
    0.0%
    Check dated 2026-04-24T16:52:39.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:43:35.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Napoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the study locations.
    Difference
    0.0%
    Check dated 2026-03-27T02:14:43.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision metadata updated: added Revision: v3.5.0 and removed Revision: v3.4.3. No study details or participant information are affected.
    Difference
    0.0%
    Check dated 2026-03-19T23:42:05.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This is a minor technical update with no changes to study content or functionality.
    Difference
    0.0%
    Check dated 2026-03-12T20:23:46.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.